Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience

BACKGROUND AND OBJECTIVES: To investigate the frequency and predictors of hypogammaglobulinemia during long-term rituximab (RTX) treatment in patients with neuromyelitis optica spectrum disorder (NMOSD) and its association with infections. METHODS: We retrospectively reviewed the data of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su-Hyun, Park, Na Young, Kim, Ki Hoon, Hyun, Jae-Won, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296048/
https://www.ncbi.nlm.nih.gov/pubmed/35853752
http://dx.doi.org/10.1212/NXI.0000000000001179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296048/
https://www.ncbi.nlm.nih.gov/pubmed/35853752
http://dx.doi.org/10.1212/NXI.0000000000001179

Ejemplares similares